| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MGTX | Ordinary Shares | Sale | -$26.1K | -1.3K | -0.15% | $20.07 | 840K | Oct 19, 2021 | Direct | F1, F2, F3 |
| transaction | MGTX | Ordinary Shares | Sale | -$288K | -13.7K | -1.64% | $20.93 | 826K | Oct 20, 2021 | Direct | F1, F3, F4 |
| transaction | MGTX | Ordinary Shares | Sale | -$148K | -6.96K | -0.84% | $21.28 | 819K | Oct 20, 2021 | Direct | F1, F3, F5 |
| holding | MGTX | Ordinary Shares | 5.15K | Oct 19, 2021 | By Spouse | ||||||
| holding | MGTX | Ordinary Shares | 25K | Oct 19, 2021 | By Aigle Healthcare Partners III LLC | F6 | |||||
| holding | MGTX | Ordinary Shares | 60K | Oct 19, 2021 | By GRAT | F6 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021. |
| F2 | The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.22, inclusive. |
| F3 | The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| F4 | The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.09 to $21.08, inclusive. |
| F5 | The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.09 to $21.59, inclusive. |
| F6 | On September 22, 2021, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person contributed 60,000 ordinary shares of the issuer owned by Aigle Healthcare Partners III LLC to a grantor retained annuity trust. |